Significance of α9β31 and αvβ 6 integrin expression in breast carcinoma

Breast Cancer

Volumn 7, Issue 1, 2000, Pages 19-26

  Arihiro, Koji ^a,b   Kaneko, Mayumi ^a   Fujii, Satoshi ^a   Inai, Kouki ^a   Yokosaki, Yasuyuki ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

^c National Hiroshima Hospital   (Japan)

Author keywords

9 31; v 6; Breast carcinoma; Immunohistochemistry; Integrins; Polyacrylamide gel electrophoresis

Indexed keywords

ALPHAVBETA6 INTEGRIN; ESTROGEN; ESTROGEN RECEPTOR; INTEGRIN; INTEGRIN ALPHA 9 BETA 1; LIGAND; TENASCIN; TUMOR ANTIGEN; TUMOR PROTEIN;

ADENOMA; ARTICLE; BREAST TUMOR; CELL MEMBRANE; CYSTOSARCOMA PHYLLOIDES; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; METABOLISM; NEOPLASM; PAGET NIPPLE DISEASE; PAPILLOMA; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ADENOMA; ANTIGENS, NEOPLASM; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MEMBRANE; ESTROGENS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; INTEGRINS; LIGANDS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PAPILLOMA; PHYLLODES TUMOR; RECEPTORS, ESTROGEN; TENASCIN;

EID: 0033660302     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967183     Document Type: Article

References (43)

1. Hynes RO: Integrins; Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
2. Koukoulis GK, Virtanen I, Korhonen M: Immunohistochemical localization of integrins in the normal, hyperplasfic, and neoplastic breast; Correlations with their functions as receptors and cell adhesion molecules. Am J Pathol 139:787-799, 1991.
3. Glukhova M, Koteliansky V, Sastre X: Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 146:706-716, 1995.
4. d'Ardenne AJ, Richman PI, Horton MA, et al: Coordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer. J Pathol 165:213-220, 1991.
5. Zutter MM, Mazoujian G, Santoro SA: Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 137:863-870, 1990. (Pubitemid 20337801)
6. Pignatelli M, Hanby AM, Stamp GWH: Low expression of ill, a2 and a3 subunits of VLA integrins in malignant mammary turnouts. J Pathol 165:25-32, 1991.
7. Jones JL, Critchley DR, Walker RA: Alteration of stromal protein and integrin expression in breast; A marker of premalignant change? J Pathol 167:399-406, 1992.
8. Pignatelli M, Cardillo MR, Hanby A, et al: Integrins and their accessory adhesion molecules in mammary carcinomas; Loss of polarization in poorly differentiated tumors. Hum Pathol23:1159-1166, 1992.
9. Arihiro K, Inai K, Kurihara K, et al: Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis. Jpn J Cancer Res 84:726-733, 1993. (Pubitemid 23230276)
10. Zutter MM, Krigman HR, Santoro SA: Altered integrin expression in adenocarcinoma of the breast. Am J Pathol 142:1439-1448, 1993.
11. Anbazhagan R, Bartek J, Stamp G, et al: Expression of integrin subunits in the human infant breast correlates with morphogenesis and differentiation. J Pathol 176:227-232, 1995.
12. Arihiro K, Inai K, Kurihara K, et al: A role of VLA-6 laminin receptor in invasion of breast carcinoma. Acta Pathol Jpn 43:662-669, 1993.
13. Natali PG, Nicotra MR, Botti C, et al: Changes in expression of a6/f14 integrin heterodimer in primary and metastatic breast cancer. Br J Cancer 66:318-322, 1992.
14. Tagliabue E, Ghirelli C, Squicciarini P, et al: Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 4:407-410, 1998. (Pubitemid 28122756)
15. Palmer EL, Ruegg C, ferrando R, et al: Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol 123:1289-1297, 1993. (Pubitemid 23352436)
16. Yokosaki Y, Palmer EL, Prieto AL, et al: The integrin α9β mediates cell attachment to a non-RGD site in the third fibronecfin type III repeat of tenascin. J Biol Chem 269:26691-26696, 1994.
17. Yokosaki Y, Matsuuta N, Higashiyama S, et al: Identification of the ligand binding site for the integrin α9β in the third fibronecfin type III repeat of tenascin-C. J Biol Chem 273:11423-11428, 1998. (Pubitemid 28272033)
18. Schneider H, Harbotfle RP, Yokosaki Y, et al: A novel pepfide, PLAEIDGIELTY, for the targeting of alpha 9 beta 1-integrins. FEBS-Lett 429:269-273, 1998.
19. Smith LL, Cheung HK, Ling LE, et al: Osteoponfin Nterminal domain contains a cryptic adhesive sequence recognized by α9β integrin. J Biol Chem 271:28485-28491, 1996. (Pubitemid 26374670)
20. Smith LL, Giachelli CM: Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. Exp Cell Res 242:351-360, 1998. (Pubitemid 28366550)
21. Weinacker A, Ferrando R, Elliott M, et al: Distribution of integrins αfβ6 and α9β and their known ligands, fibronectin and tenascin, in human airways. Am J Respir Cell Mol Biol 12:547-557, 1995.
22. Sheppard D, Yokosaki Y: Roles of airway epithelial integrins in health and disease. Chest 109 (suppl): 29S-33S, 1996.
23. Wang A, Patrone L, McDonald JA, et al: Expression of the integrin subunit alpha 9 in the murine embryo. Dev Dyn 204:421-431, 1995.
24. Stepp MA, Zhu L: Upregulation of alpha 9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem 45: 189-201, 1997. (Pubitemid 27114490)
25. Turbat-Harrera EA, Isaac J, sanders PW, et al: Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chan-related renal disease. Mod Pathol 10:485-495, 1997. (Pubitemid 27244237)
26. Basora N, Desloges N, Chang Q, et al: Expression of the a 9 l1 integrin in human colonic epithelial cells; Resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int J Cancer 75:738-743, 1998. (Pubitemid 28145821)
27. Sheppard D, Rozzo C, Starr L, et al: Complete amino acid sequence of a novel integrin beta subunit (beta identified in epithelial cells using the polymerase chain reaction.JBiol Chem 265:11502-11507, 1990.
28. Busk M, Pytela R, Sheppard D: Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J Biol Chem 267:5790-5796, 1992.
29. Weinacker A, Chen A, Agrez M, et al: Role of the integrin alpha v beta 6 in cell attachment to fibronectin; Heterologous expression of intact and secreted forms of the receptor. J Biol Chem 269:6940-6948, 1994.
30. Prieto AL, Edelman GM, Crossin KL: Multiple integrins mediate cell attachment to cytotacfin/tenascin. Proc Natl Acad Sci USA 90:10154-10158, 1993. (Pubitemid 23328270)
31. Breuss JM, Gillett N, Lu L, et al: Restricted distribution of integrin beta 6 mRNA in primate epithelial fissues.J Histochem Cytochem 41:1521-1527, 1993. (Pubitemid 23275254)
32. Haapasalmi K, Zhang K, Tonnesen M, et al: Keratinocytes in human wounds express alpha v beta 6 integrin. J Invest Dermatol 106:42-48, 1996. (Pubitemid 26052049)
33. Breuss JM, Gallo J, DeLisser HM, et al: Expression of the t9 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 108:2241-2251, 1995.
34. Pilewski JM, Latoche JD, Arcasoy SM, et al: Expression of integrin cell adhesion receptors during human airway epithelial repair in vivo. Am J Physiol 273:256-263, 1997.
35. Huang XZ, Wu JF, Cass D, et al: Inactivation of the integrin 9 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and sldn.J Cell Biol 133:921-928, 1996. (Pubitemid 26160991)
36. Agrez MV, Shafren DR, Gu X, et al: Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells. Virology 239:71-77, 1997. (Pubitemid 28027071)
37. Jones J, Watt FM, Speight PM: Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med 26:63-68, 1997. (Pubitemid 27157727)
38. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer; A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359-377, 1957.
39. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-complex (ABC) in immunoperoxidase techniques; A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981. (Pubitemid 11147380)
40. Karneda T, Yasui W, Yoshida K, et al: Expression of ERBB2 in human gastric carcinomas; Relationship between p185ERBB2 expression and the gene amplification. Cancer Res 50:8002-8009, 1990.
41. Yasui W, Ayhan A, Kitadai Y, et al: Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 53:1-6, 1992.
42. Arihiro K, Inai K, Kurihara K, et al: Distribution of laminin, type IV collagen and fibronectin in the invasive component of breast carcinoma. Acta Pathol Jpn 43:758-764, 1993.
43. Bellahcene A, Castronovo V: Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146:95-100, 1995.